Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07570433Phase 4Not Yet Recruiting

HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial

Role: collaborator

NCT07107009Not Yet Recruiting

ClimAIr: AI to Assess the Impact of Pollution and Climate on Respiratory Health in Europe

Role: collaborator

NCT02783781Completed

Contribution of Preoperative Biological Data in Risk Assessment in Cardiac Surgery in Addition to the EuroSCORE (EuroSCOREbio)

Role: collaborator

All 3 trials loaded